Unternehmen Gracell Biotechnologies Inc.
Aktien
A2QL6Y
US38406L1035
GRCL
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 314
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01.05.17 |
Yi Li Xie
DFI | Director of Finance/CFO | 54 | 24.07.20 |
Wendy Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 01.08.22 |
Gracie Tong
IRC | Investor Relations Contact | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 01.05.17 |
Guo Tong Xu
BRD | Director/Board Member | 67 | 01.02.19 |
Guo Wei Wang
BRD | Director/Board Member | 63 | 01.03.20 |
Kin Ping Lee
BRD | Director/Board Member | 54 | 09.07.21 |
Wendy Hayes
BRD | Director/Board Member | 54 | 07.01.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 61 364 562 | 0 | 0 | 83,58 % |
Aktie B | 0 | 59 327 653 | 0 | 0 | |
Aktie C | 1 | 479 632 139 | 400 876 542 ( 83,58 %) | 0 | |
Aktie D | 0 | 21 735 721 | 0 | 0 | |
Aktie E | 0 | 31 343 284 | 0 | 0 |
Unternehmenskontakt
Gracell Biotechnologies, Inc.
Biobay & Suzhou Industrial Park 218 Sangtian Street
215123, Suzhou
+
http://www.gracellbio.com![Straße Gracell Biotechnologies Inc.(GRCL)](https://cdn.zonebourse.com/static/address/117317674.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+18.97% | 45.34 Mrd. | |
+41.98% | 40.42 Mrd. | |
-10.06% | 37.92 Mrd. | |
+31.15% | 31.75 Mrd. | |
-7.79% | 27.71 Mrd. | |
+13.32% | 26.52 Mrd. | |
+43.05% | 13.96 Mrd. | |
+31.28% | 12.44 Mrd. | |
-7.41% | 11.26 Mrd. |